Re: Evista in premenopausal women

From: Ana (aocana58@yahoo.com)
Mon Nov 29 09:00:26 2004


Evista is not indicated in premenopausal women because it depletes estrogen levels. Remember raloxifene is a SERM (selective estrogen receptor modulator) and produces vasomotor symptoms. Greetings from Mexico Ana Ocaņa MD

--- "Richard Chudacoff, MD" <rchudacoff@mylinuxisp.com> wrote:

> Is there any indication for Evista in premenopausal
> women? I have two
> patients from the same FP now, who is giving it for
> osteopenia (not a
> condition I recognize as needing treatment.)
>
> Richard Chudacoff, MD
>
> Chudacoff OB & GYN, PA
>
> 15200 Soutwest Freeway #270
>
> Sugar Land, TX 77478
>
> tel: 281-277-3900
>
> fax: 281-277-3901
>
> Email: Richard.Chudacoff@obgyn.net
>
> rchudacoff@mylinuxisp.com
>

Tired of spam? Yahoo! Mail has the best spam protection around





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Sat Aug 2 04:44:21 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.